Levo Therapeutics
Skokie, US · Founded 2015 · Delaware corporation
Founders & leadership
SC
Sara CotterNamed on SEC filing
MD
Michael DybbsNamed on SEC filing
SB
Sara BrownsteinNamed on SEC filing
TK
Terrence KearneyNamed on SEC filing
DW
Daniel WelchNamed on SEC filing
SR
Steven RyderNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$86.5M disclosed across 2 rounds · 2017–2019
▶$40MraisedNov 2019 · 4 investors · Other Health CareRule 506(b)
▶$40MraisedNov 2019 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Sara CotterExecutive Officer, Director, Promoter
- Michael DybbsDirector
- Sara BrownsteinDirector
- Terrence KearneyDirector
- Daniel WelchDirector
- Steven RyderDirector
- Offering amount
- $40M
- Amount sold
- $40M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$46.5MraisedNov 2019 · 5 investors · Other Health CareRule 506(b)
▶$46.5MraisedNov 2019 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Sara BrownsteinDirector
- Terrence KearneyDirector
- Daniel WelchDirector
- Steven RyderDirector
- Michael DybbsDirector
- Sara CotterExecutive Officer, Director, Promoter
- Offering amount
- $46.5M
- Amount sold
- $46.5M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Levo Therapeutics raised?
- Levo Therapeutics has disclosed $86.5M raised across 2 rounds.
- Where is Levo Therapeutics headquartered?
- Levo Therapeutics is headquartered in Skokie, US.